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Abstract
The microbiota is required for optimal host development and ongoing immune homeostasis.
Lactobacilli are common inhabitants of the mammalian large intestine and immunoregulato-
ry effects have been described for certain, but not all, strains. The mechanisms underpin-
ning these protective effects are beginning to be elucidated. One such protective organism
is Lactobacillus rhamnosus JB-1 (Lb. rhamnosus JB-1). Lb.murinus has no such anti-in-
flammatory protective effects and was used as a comparator organism. Human monocyte-
derived dendritic cells (MDDCs) were co-incubated with bacteria and analysed over time for
bacterial adhesion and intracellular processing, costimulatory molecule expression, cyto-
kine secretion and induction of lymphocyte polarization. Neutralising antibodies were uti-
lized to identify the responsible MDDC receptors. Lb. rhamnosus JB-1 adhered to MDDCs,
but internalization and intracellular processing was significantly delayed, compared to Lb.
murinus which was rapidly internalized and processed. Lb.murinus induced CD80 and
CD86 expression, accompanied by high levels of cytokine secretion, while Lb. rhamnosus
JB-1 was a poor inducer of costimulatory molecule expression and cytokine secretion. Lb.
rhamnosus JB-1 primed MDDCs induced Foxp3 expression in autologous lymphocytes,
while Lb.murinus primed MDDCs induced Foxp3, T-bet and Ror-γt expression. DC-SIGN
was required for Lb. rhamnosus JB-1 adhesion and influenced IL-12 secretion, while TLR-2
influenced IL-10 and IL-12 secretion. Here we demonstrate that the delayed kinetics of bac-
terial processing by MDDCs correlates with MDDC activation and stimulation of lympho-
cytes. Thus, inhibition or delay of intracellular processing may be a novel strategy by which
certain commensals may avoid the induction of proinflammatory responses.
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Introduction
It is well accepted that the gut microbiota plays a pivotal role in mucosal immune system devel-
opment and ongoing homeostasis [1–3]. Moreover, a diverse gut microbiota contributes to ap-
propriate digestion of dietary substances, protects against pathobiont expansion, provides
nutrients for the host and ensures appropriate development of the mucosal barrier [4–6]. The
mechanisms underpinning these protective responses are varied and include not only intact
microbial cell interaction with host receptors, but also microbial metabolic activity, including
short chain fatty acid production and bile degradation, which influences biological functions of
the whole organism [7–9].
Crosstalk between the microbiota and the host is tightly regulated. Expression of pattern
recognition receptors (PRRs) allows the immune system to discriminate between commensal
and harmful microbes. Activation of diverse PRRs leads to differential cascades in signaling
pathways and subsequently polarized secretion of cytokines and metabolites. Certain protective
microbes interact with mucosal cells and contribute to the maintenance of mucosal tolerance
[10–12]. In recent years, Lactobacilli strains have been repeatedly shown to have many benefi-
cial effects within the gut [13]. Many diverse species and strains have been well characterized.
Lactobacillus rhamnosus JB-1 (Lb. rhamnosus JB-1) has been well described as a tolerogenic
commensal microbe, with multiple effects on mucosal cells including the induction of Foxp3+
T regulatory cells [14–16]. In addition, this microbe exerts potent effects on the gut-brain axis
[17]. However, not all Lactobacillus strains exert the same effects, for example Lactobacillus sal-
ivarius AH102 does not induce T regulatory cells [18].
The molecular mechanisms underpinning the tolerogenic effects of Lactobacilli are diverse
and are only beginning to be described in detail. Peptidoglycan-associated muropeptide pro-
duced by Lactobacillus salivarius Ls33 is thought to be responsible for its anti-inflammatory ef-
fect [19]. Lipoteichoic acid D-alanylation decreases anti-inflammatory responses associated
with Lactobacillus plantarum and Lactobacillus acidophilus [20, 21]. Following removal of this
modification, mutants were more efficient in their ability to protect against colitis in murine
models. Moreover, secreted proteins such as p40 and p70 from Lactobacillus rhamnosus GG
have been shown to enhance a functional epithelial barrier and improve cell survival [22–24].
Even small differences, such as glycosylation patterns, in cell-wall composition can lead to op-
posing effects on immune responsiveness [25, 26]. Indeed, the amount of a specific metabolite
being secreted by a specific strain can have protective or pathological effects on the host im-
mune system. For example, a Lb. rhamnosus strain, which secretes a low level of histamine, ex-
erts protective immunological effects, while a Lb. saerimneri strain, which secretes high levels
of histamine, induces an inflammatory response within the gut [27, 28]. However it is likely
that many more, yet undiscovered, molecular mechanisms are involved and the data so far sug-
gest that many of these mechanisms are bacterial strain and context dependent.
This diversity in molecular mechanisms is important, not least because mucosal recognition
of bacterial strains via multiple PRRs on dendritic cells (DCs) will lead to divergent and polar-
ized adaptive responses [29]. Typically, DCs will bind bacteria, internalize the microbe, lyse the
bacterium within activated lysosomes and present the microbial antigens in the context of
MHC. This response is accompanied by upregulation of costimulatory molecules and cytokine
secretion in order to induce the appropriate tissue and adaptive immune responses. However,
the combined examination of DC processing and cytokine secretion, in response to Lactobacilli
strains, has not been previously described. In this report, we demonstrate an association be-
tween delayed DC intracellular processing of Lb. rhamnosus JB-1, which is associated with
poor induction of costimulatory molecule expression and cytokine secretion, with preferential
Dendritic Cell Responses to Lactobacillus rhamnosus JB-1
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induction of Foxp3+ lymphocytes and no induction of TH1 or TH17 transcription factors.
These responses are partially mediated via TLR-2 and DC-SIGN.
Results
MDDCs efficiently bind Lb. rhamnosus JB-1, but display delayed
internalization and processing
Human monocyte-derived dendritic cells (MDDCs) efficiently bind Lb. rhamnosus JB-1 as
demonstrated by multispectral image stream analysis (Fig. 1A). In order to examine Lb. rham-
nosus JB-1 internalisation and processing in more detail, we further examined MDDC re-
sponses to this microbe over an extended timeframe using confocal microscopy (Fig. 1B).
Surprisingly, MDDCs did not internalize Lb. rhamnosus JB-1 for at least 48 hours following
co-incubation, despite binding a large number of microbes on the cell surface. In addition, the
binding pattern was unusual as distinct clustering of the bound microbe around the nucleus of
the MDDCs was evident, even up to 96 hours following co-incubation. This delay in processing
of Lb. rhamnosus JB-1 was not oberserved for an unrelated Lb.murinus strain (Fig. 1C), while
the peri-nuclear binding was also not observed for Lb.murinus. Internalization of Lb. rhamno-
sus JB-1 was shown to peak at 48 hours as antibiotic treatment of the dendritic cells kills bacte-
ria on the surface of the cells, while internalized bacteria are protected from the antibiotic
allowing their growth and enumeration on agar plates (Fig. 2A). In addition, phagocytosis of
fluorescently labeled E. coli was delayed in Lb. rhamnosus JB-1 treated dendritic cells, but not
in Lb.murinus treated dendritic cells (Fig. 2B).
Distinct MDDC responses are induced by two Lactobacillus strains
Following activation, MDDCs upregulate expression of cell surface co-stimulatory molecules
and secrete cytokines. LPS stimulation resulted in robust stimulation of CD80/CD86 double
positive MDDCs, followed by Lb.murinus, while Lb. rhamnosus JB-1 was a poor inducer of
CD80/CD86 expression (Fig. 3A). Lb. rhamnosus JB-1-stimulated expression of CD80 and
CD86 was significantly less than that induced by LPS or Lb.murinus.
MDDCs were co-incubated with 1x105 or 1x106 bacterial cells, and their supernatant cyto-
kine levels were quantified after 24 hours. Lb.murinus induced high levels of TNF-α, IL-6, IL-
10, IL-12p70, G-CSF and MCP-1. However, stimulation with Lb. rhamnosus JB-1 resulted in
significantly less cytokine secretion, for all the cytokines measured (Fig. 3B). The relatively
poor induction of co-stimulatory molecule expression and cytokine secretion by Lb. rhamnosus
JB-1 is consistent with the imaging results, whereby the dendritic cell response to this bacteri-
um seems to be minimal. SOCS3 has been previously described to suppress cytokine responses
via negative regulation of MAP kinase activation. Lb. rhamnosus JB-1-stimulated MDDCs
upregulated SOCS gene expression and p38 MAPK responses were significantly less than for
LPS stimulated cells (S1 Fig.).
In order to further compare and contrast the dendritic cell response to these two lactobacilli
strains, we co-incubated bacterial-stimulated dendritic cells with autologous lymphocytes for 7
days. Both Lb. rhamnosus JB-1 and Lb.murinus-stimulated MDDCs induced Foxp3 expression
in autologous lymphocyte (Fig. 4). However, Lb.murinus-stimulated MDDCs also induced ex-
pression of T-bet (TH1) and ror-γt (TH17) transcription factors (Fig. 4). Lb. rhamnosus JB-1-
stimulated MDDCs did not alter expression of the TH1 or TH17 transcription factors in autolo-
gous lymphocytes, when compared to transcription factor levels in control cultures (i.e. non-
stimulated MDDCs and autologous lymphocytes co-incubation for 7 days).
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DC-SIGN, but not TLR-2, is required for Lb. rhamnosus JB-1 binding to
MDDCs
In order to further investigate the receptors that may be involved in MDDC recognition of Lb.
rhamnosus JB-1, we specifically examined the role for DC-SIGN and TLR-2 as they have been
Fig 1. Differential MDDC binding and processing of two Lactobacilli strains.MDDCs bind Lb.
rhamnosus JB-1 efficiently but intracellular processing is delayed, as visualized by multispectral flow
cytometry imaging (A) and confocal microscopy (B). Lb.murinus is also efficiently bound by MDDCs and is
rapidly processed (C). For both strains, bacterial cells are CFSE labeled (green), while CD11c+ cells are PE-
Cy5 stained (red).
doi:10.1371/journal.pone.0120261.g001
Dendritic Cell Responses to Lactobacillus rhamnosus JB-1
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previously shown by us and others to recognize commensal and pathogenic microbes. Firstly
we assessed if c-type lectin receptors (CLRs) are required by comparing MDDC binding under
calcium free conditions. MDDC capture of Lb. rhamnosus JB-1 was reduced by approximately
55% when calcium was absent from the medium suggesting that CLRs might be involved
(Fig. 5A). DC-SIGN is a CLR previously described to recognize certain lactobacillus strains.
When DC-SIGN was blocked using a neutralizing antibody, Lb. rhamnosus JB-1 adhesion to
MDDCs was significantly reduced and the peri-nuclear clustering pattern was substantially re-
duced (Fig. 5B). However, neutralization of TLR-2 had no effect on Lb. rhamnosus JB-1 adhe-
sion (Fig. 5B).
Lb. rhamnosus JB-1 stimulation of MDDC cytokine secretion is DC-
SIGN and TLR-2 dependent
MDDCs were pre-incubated with specific blocking antibodies for TLR-2 or DC-SIGN prior to
bacteria stimulation and cytokine secretion was analyzed after 24 hours. Inhibition of TLR-2
Fig 2. Lb. rhamnosus JB-1 internalisation by MDDCs. (A) Following antibiotic treatment, which kills bacteria outside MDDCs, the peak recovery of viable
Lb. rhamnosus JB-1 was observed after 48 hours, suggesting that this was the time point when the bacteria were internalized by the MDDCs. (B) MDDC
phagocytosis of another bacterial strain, E. coli, was reduced when the MDDCs were co-exposed to Lb. rhamnosus JB-1, but not Lb.murinus.
doi:10.1371/journal.pone.0120261.g002
Dendritic Cell Responses to Lactobacillus rhamnosus JB-1
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signalling resulted in significantly decreased secretion of IL-10, associated with increased secre-
tion of IL-12p70 in response to Lb. rhamnosus JB-1 (Fig. 6A). However, neutralization of TLR-
2 activation did not alter the IL-10 or IL-12 response to Lb.murinus (Fig. 6A). Blockade of
DC-SIGN had no effect on IL-10 or TNF-α secretion, while IL-12p70 secretion in response to
Fig 3. MDDC costimulatory molecule expression and cytokine secretion. (A) CD80 and CD86 were upregulated on MDDCs after exposure to both
bacterial strains. LPS served as a positive control. Co-stimulatory molecule expression was significantly higher after stimulation with Lb.murinus compared
with Lb. rhamnosus JB-1. (B) Lb.murinus stimulated MDDC cytokine secretion was significantly higher, for all cytokines tested, compared to that induced by
Lb. rhamnosus JB-1 (n = 5 donors). *p<0.05
doi:10.1371/journal.pone.0120261.g003
Dendritic Cell Responses to Lactobacillus rhamnosus JB-1
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Lb. rhamnosus JB-1 was significantly reduced. DC-SIGN neutralization had no effect on Lb.
murinus-stimulated MDDC cytokine responses (Fig. 6A). We further confirmed that TLR-2
recognises Lb. rhamnosus JB-1 by utilizing HEK-293 cells, which express TLR-2. These cells re-
sponded to Lb. rhamnosus JB-1, as demonstrated by an increase in NF-κB/AP-1 activation,
while neutralizing TLR-2 antibodies significantly reduced this response (Fig. 6B). In addition,
Fig 4. Transcription factor expression in lymphocytes co-incubated with bacterial primed MDDCs. Following 7 days co-incubation, MDDCs primed by
both bacterial strains induced CD25+Foxp3+ T regulatory cells, while only MDDCs exposed to Lb.murinus increased T-bet and Ror-γt positive CD4+ T cells.
doi:10.1371/journal.pone.0120261.g004
Dendritic Cell Responses to Lactobacillus rhamnosus JB-1
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TLR-2 deficient HEK-293 did not respond to Lb. rhamnosus JB-1 (Fig. 6B). MDDCs also ex-
press high levels of Dectin-1 and we performed blocking experiments for this receptor to inves-
tigate its role in cytokine secretion in response to Lb. rhamnosus JB-1. However, there was no
significant difference in cytokine production following Dectin-1 neutralisation (data not
shown).
Discussion
In this report we demonstrate that the kinetics of DC processing and the magnitude of cellular
activation induced by Lb. rhamnosus JB-1 are significantly different than that of another strain,
Lb.murinus. At least two different PRRs are involved in this response, DC-SIGN and TLR-2.
Even though Lb. rhamnosus JB-1 does not strongly stimulate DC responses, primed DCs are
Fig 5. Lb. rhamnosus JB-1 is bound by MDDCDC-SIGN. (A) Lb. rhamnosus JB-1 binding to MDDCs is
partially dependent on the presence of Ca2+ ions, suggesting the involvement of CLRs. The flow cytometry
plots are representative of 3 independent experiments. (B) As visualized by confocal microscopy, blockade of
DC-SIGN decreased Lb. rhamnosus JB-1 binding to MDDC, while neutralizing TLR-2 antibodies had no
effect on Lb. rhamnosus JB-1 binding.
doi:10.1371/journal.pone.0120261.g005
Dendritic Cell Responses to Lactobacillus rhamnosus JB-1
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capable of inducing Foxp3 expression in lymphocytes. Lb.murinus primed DCs also induce
Foxp3 expression but this is associated with T-bet and ror-γt expression.
These data suggest that one mechanism that may be exploited by Lb. rhamnosus JB-1 to pre-
vent excessive inflammatory responses against this non-pathogenic microbe is to suppress DC
Fig 6. MDDC TLR-2 and DC-SIGN are required for appropriate cytokine responses to Lb. rhamnosus JB-1. (A) Lb. rhamnosus JB-1 or Lb.murinus-
stimulated MDDCs were pre-incubated with blocking antibodies for TLR-2 (n = 8 donors), DC-SIGN (n = 8 donors) or antibody isotype controls for 30 minutes
prior to stimulation and cytokine secretion was analyzed after 24 hours. Results are expressed as the mean pg/ml +/− standard error. (B) TLR-2 activation
was confirmed using HEK-293 cells which express TLR-2. *p<0.05
doi:10.1371/journal.pone.0120261.g006
Dendritic Cell Responses to Lactobacillus rhamnosus JB-1
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activation. The data also suggest that this is an active process, rather than a passive process
whereby the strain is simply not recognized by the DC. Blockade of TLR-2 results in less IL-10
being secreted, but more IL-12p70, a TH1 associated cytokine. In contrast, blockade of DC-
SIGN results in reduced secretion of IL-12p70. This suggests that TLR-2 and DC-SIGN activa-
tion both influence different aspects of the DC response to Lb. rhamnosus JB-1.
TLR-2 is widely described as a PRR mediating host protective immune responses. In gener-
al, TLR-2−/− DCs are not efficient in promoting Foxp3 Treg cell development and IL-10 secre-
tion in vitro [30, 31]. Moreover, TLR-2-/- mice are more susceptible to DSS- induced colitis.
TLR-2 activation by Lb. rhamnosus JB-1 is required for IL-10 secretion, while TLR-2 activation
suppresses IL-12p70. The link between TLR-2 activation and suppression of IL-12 or CXCL-10
is unknown, however, SOCS3 gene expression is increased by Lb. rhamnosus JB-1-stimulated
MDDCs. SOCS3 has been previously described to suppresses p38 MAPK and IL-12, IL-6,
TNF-α and IL-23 secretion [32]. Thus SOCS3 induction by TLR-2 may be important for the
low level of cytokine secretion induced by Lb. rhamnosus JB-1. Interestingly, not all lactobacilli
strains can activate TLR-2, suggesting that strain-specific immunoregulatory effects may be
partially mediated via TLR-2 activation [33].
DC-SIGN is a type II C-type lectin with a single carbohydrate recognition domain. DC-
SIGN has been demonstrated to recognize a wide variety of pathogens and commensals includ-
ing viruses such as HIV-1 and Ebola and bacteria such asMycobacterium tuberculosis, Lactoba-
cillus casei and Bifidobacterium infantis [34–36]. DC-SIGN recognizes mannose-capped
lipoarabinomannan (ManLam) on Mycobacteria and activation of dendritic cells with Man-
Lam leads to the generation of Foxp3+ Tregs involving a PGE2 dependent process [37]. DC-
SIGN was previously shown to be important for lactobacillus primed MDDCs driven T regula-
tory cell development [38]. DC-SIGN and TLR-2 are required for IL-10 secretion and Foxp3
induction by another immunoregulatory microbe, Bifidobacterium infantis 35624 [35]. How-
ever, MDDCs process this Bifidobacterium strain very rapidly (less than 24 hours) suggesting
that additional TLR-2/DC-SIGN independent Lb. rhamnosus JB-1-associated factors are re-
sponsible for the delayed intracellular processing and peri-nuclear clustering of this strain on
human MDDCs.
A wide variety of Lactobacilli strains have been isolated from the human gastrointestinal
tract and the majority have been shown to be commensal inhabitants of mammalian large in-
testine. However, certain strains have now clearly been demonstrated to exert additional bene-
ficial effects on host immunoregulatory processes, such as that already described for Lb.
rhamnosus JB-1. This microbe has shown protective effects in a range of murine models and
we now describe certain potential cellular mechanisms underpinning this regulatory response.
Manipulation of regulatory DC and T regulatory cell numbers or functions is an exciting thera-
peutic target in a wide range of inflammatory diseases [39, 40]. A clearer understanding of the
mechanisms employed in vivo for the induction of oral tolerance by the microbiota will likely
result in rational strategies to manipulate both regulatory and effector T cells, thereby influenc-
ing gastrointestinal disorders such as food allergy, eosinophilic esophagitis, irritable bowel syn-
drome and inflammatory bowel diseases.
Materials and Methods
Dendritic cell isolation and culture conditions
Monocytes and T cells were obtained from healthy volunteers. Human peripheral blood mono-
cytes were isolated using CD14 positive isolation with the MACS system (Miltenyi Biotec, 130-
050-201). Cells were cultured in cRPMI media (Life Technologies, 21875-091) with interleukin
4 1000U/ml (Novartis) and granulocyte macrophage colony stimulating factor (PeproTech,
Dendritic Cell Responses to Lactobacillus rhamnosus JB-1
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300-03) 1000U/ml for 5–6 days in order to differentiate them into monocyte-derived dendritic
cells (MDDCs). Human peripheral blood CD4 T cells were isolated using negative selection
with the MACS system. Purified cells were cultured in AIM-V media (Life Technologies,
12055091). MDDCs were cultured in cRPMI and stimulated for 24 hours with different doses
of Lactobacillus rhamnosus JB-1, Lactobacillus murinus (both gifts from the Alimentary Health
culture collection, Cork, Ireland) or 0.5μg/ml LPS (Sigma- Aldrich). Cells were pre-incubated
with the blocking monoclonal antibodies: anti-TLR2 antibody 4μg/ml (gift from C. Kirschning,
Munich), anti-DC-SIGN 2μg/ml (AZDN1) (Beckman Coulter, A07406) or IgG2B control anti-
body, clone 20116 (R&D Systems Europe, MAB004) for 30 minutes. Cytokine secretion was ex-
amined by Bio-Plex multiplex suspension array (Bio-Rad Laboratories). The costimulatory
molecules CD80 and CD86 expression on MDDCs were measured with anti-CD80 FITC and
anti- CD86 PE (Beckman Coulter) by flow cytometry. MDDCs were incubated with 5x106 bac-
teria for 4, 8, 12, 16, 20 or 24 hours and mRNA was isolated by use of RNeasy Mini kit (Qiagen,
Venlo, Netherlands). Reverse transcription was performed with Fermentas reagents, including
hexamer primers (St. Leon-Rot, Germany). Real time PCR was performed with iTaq SYBR
Green Supermix with ROX (Bio-Rad Laboratories, Hercules, USA) and primers: EF1a Fw:
CTGAACCATCCAGGCCAAAT, EF1a Rv: GCCGTGTGGCAATCCAAT; SOCS3 Fw:
TGTTTACAATCTGCCTCAATCACTCT, SOCS3 Rv: TCAAGCATCTCCTAATAGCCT-
CAA, synthesized by Microsynth (Balgach, Switzerland).
Phagocytosis assay
MDDCs were plated at a density of 2x106 per well in a 6-well plate. They were incubated alone
or with Lactobacillus rhamnosus JB-1 or Lactobacillus murinus at 37°C, 5% CO2 for 4 hours to
24 hours. Bacteria were added at a 1:1 ratio with MDDCs. After the incubation period,
MDDCs were washed with PBS, harvested and incubation with pHrodo Green E. coli BioParti-
cles Conjugate for Phagocytosis (Molecular Probes) was performed. Flow cytometry was per-
formed using Galios flow cytometer (Beckman Coulter). Kaluza software (Beckman Coulter)
was used for the analysis of pHrodo Green E. coli BioParticles Conjugate positive cells.
Internalization assay
MDDCs were incubated alone or with Lactobacillus rhamnosus JB-1 at 37°C, 5% CO2 for 4
hours to 96 hours. Bacteria were added at a 10:1 ratio with MDDCs. After the incubation peri-
od, gentamicin (100μg/ml) was added to kill extracellular bacteria. After 2 hours, the superna-
tant was removed, the cells were washed with PBS and 1% Triton X-100 was used to lyse
dendritic cells and allow the release of internalized bacteria. Plating of serial dilutions on MRS
agar (Merck, VWR International, Dietikon, Switzerland) followed by conventional plate count-
ing was performed.
MDDC-T cell co-cultures
MDDCs were stimulated for 4 hours with Lactobacillus rhamnosus JB-1 or Lactobacillus muri-
nus and co-cultured with T cells from autologous donors at a ratio of 1:20 in AIM-V media.
After 5 days cells were stimulated with CDMix: anti-human CD28 (generated in house), anti-
human CD3 (Orthoclone OKT3, Janssen-Cilag) and anti-human CD2 (CLB-T11.2/1 and CLB-
T11/1, Sanquin, M1652, M1651). Two days later cells were removed from culture and stained
for CD4, CD25, Foxp3, T-bet and Ror-γt expression using flow cytometry (eBioscience, San
Diego).
Dendritic Cell Responses to Lactobacillus rhamnosus JB-1
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Bacteria labeling and visualization
Bacteria were stained with carboxyfluorescein diacetate, carboxyfluorescein succinimidyl ester
(CFSE) (Life technologies, C1157), while MDDCs were stained with anti-human CD11c PE-
Cy5, clone B-ly6 (BD Pharmingen). MDDCs were incubated with CFSE-labeled bacteria for 4
hours in HBSS with or without calcium and magnesium. Binding was analyzed flow cytometry.
Moreover, bacteria binding in cRPMI was visualized after 24 and 72 hours by use of multispec-
tral imaging flow cytometer Image Stream X (Amnis Corporation) and images were analyzed
with IDEAS software (Amnis Corporation). MDDCs were plated on round cover slips and in-
cubated with bacteria for 4, 24, 48 or 96 hours with or without blocking monoclonal antibodies.
Cells were additionally stained with DAPI in ProLong Gold antifade reagent (Life Technolo-
gies, P36935). Slides were analyzed by confocal microscopy.
HEK-293 cells
HEK-Blue hTLR2 cells and HEK-Blue Null1 cells (Invivogen) were pre-incubated with anti-
TLR2 antibody for 30 minutes and were stimulated with 1x105 bacteria for 24 hours. Both cell
lines express NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP). NF-κB induc-
tion was measured indirectly by quantifying the enzymatic reaction with Quanti blue reagent
(Invivogen, rep-qb1) and spectrophotometry.
Statistical analysis
Unpaired student t-tests were used to compare bacterial-stimulated MDDC cytokine secretion
levels. Wilcoxon matched-pairs test was used to evaluate the effect of blocking antibodies on
activated dendritic cells. All data analysis was performed using GraphPad Prism software.
Supporting Information
S1 Fig. Lb. rhamnosus JB-1-stimulated MDDCs upregulated SOCS gene expression and
p38 MAPK responses were significantly less than for LPS stimulated cells.
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